Seeking Alpha

Rexahn Pharmaceuticals (RNN +6.3%) says Teva (TEVA -0.6%) has submitted an IND for the small...

Rexahn Pharmaceuticals (RNN +6.3%) says Teva (TEVA -0.6%) has submitted an IND for the small molecule chemotherapy agent RX-3117. The companies established a commercialization and development agreement for the drug in 2009.
Comments (2)
  • asms
    , contributor
    Comments (38) | Send Message
     
    I sold RNN last week, Planning to buy again.
    15 Jul 2013, 10:13 AM Reply Like
  • joe kelly
    , contributor
    Comments (1725) | Send Message
     
    I feel your pain. Sold INO too early. Holding RNN ultra long from .32.
    15 Jul 2013, 10:47 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|